Eloxx Pharmaceuticals (ELOX) Institutional Ownership $0.0002 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for Eloxx Pharmaceuticals (NASDAQ:ELOX)CurrentInstitutional OwnershipPercentage2.90%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$1.32MNumber ofInstitutional Sellers(last 12 months)0 Get ELOX Insider Trade Alerts Want to know when executives and insiders are buying or selling Eloxx Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ELOX Institutional Buying and Selling by Quarter Ad Porter & CompanyTrue paradigm shiftI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. Eloxx Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2023Armistice Capital LLC275,000$1.32M0.0%N/A10.000% 2/13/2023American Financial Group Inc.37,000$67K0.0%-97.5%1.705% 2/13/2023Clal Insurance Enterprises Holdings Ltd14,626$27K0.0%-97.5%0.674% 1/26/2023 Harel Insurance Investments & Financial Services Ltd.29,410$54K0.0%-97.5%1.355% 7/25/2022Silverarc Capital Management LLC1,041,499$281K0.1%-46.6%1.202% 2/10/2022B. Riley Wealth Management Inc.48,500$34K0.0%N/A0.056% Get the Latest News and Ratings for ELOX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eloxx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/7/2022 Harel Insurance Investments & Financial Services Ltd.1,176,401$831K0.0%N/A1.364% 2/2/2022 Vanguard Capital Wealth Advisors158,900$111K0.1%-63.7%0.184% 11/17/2021Altium Capital Management LP1,118,000$1.82M0.4%+66.8%1.296% 11/16/2021Two Sigma Advisers LP705,300$1.15M0.0%+214.2%0.818% 11/16/2021Two Sigma Investments LP314,874$513K0.0%+195.7%0.365% 11/15/2021Natixis103,900$170K0.0%N/A0.120% 11/12/2021Geode Capital Management LLC772,836$1.26M0.0%+46.6%0.897% 11/9/2021Sawtooth Solutions LLC16,201$26K0.0%N/A0.019% 11/9/2021BlackRock Inc.490,871$800K0.0%+157.4%0.569% 11/1/2021 Vanguard Capital Wealth Advisors437,900$457K0.3%+250.3%0.508% 10/14/2021 Private Advisor Group LLC32,510$52K0.0%N/A0.038% 8/17/2021Millennium Management LLC393,703$783K0.0%N/A0.823% 8/17/2021Bridgeway Capital Management LLC149,000$297K0.0%-12.8%0.311% 8/16/2021LMR Partners LLP14,435$29K0.0%N/A0.030% 8/16/2021Cubist Systematic Strategies LLC83,344$166K0.0%N/A0.174% 8/16/2021Nantahala Capital Management LLC2,266,287$4.51M0.1%N/A4.736% 8/16/2021Occudo Quantitative Strategies LP42,247$84K0.0%N/A0.088% 8/16/2021Charles Schwab Investment Management Inc.367,062$731K0.0%+125.5%0.767% 8/16/2021State Street Corp189,203$377K0.0%-56.8%0.395% 8/13/2021Renaissance Technologies LLC163,900$326K0.0%N/A0.342% 8/13/2021Northern Trust Corp136,872$273K0.0%-53.2%0.286% 8/13/2021Altium Capital Management LP670,118$1.33M0.3%N/A1.400% 8/13/2021Geode Capital Management LLC527,307$1.05M0.0%+18.8%1.102% 8/13/2021Vanguard Group Inc.3,055,517$6.08M0.0%+156.2%6.385% 8/12/2021XTX Topco Ltd46,884$93K0.0%N/A0.098% 8/12/2021Ergoteles LLC121,900$243K0.0%N/A0.255% 8/11/2021Deutsche Bank AG68,000$135K0.0%+279.6%0.142% 8/9/2021Meeder Asset Management Inc.20,457$41K0.0%+242.3%0.043% 8/3/2021Victory Capital Management Inc.12,359$25K0.0%N/A0.026% 7/28/2021 Vanguard Capital Wealth Advisors125,000$248K0.2%N/A0.261% 5/13/2021Barclays PLC22,278$74K0.0%+159.0%0.047% 5/12/2021Northern Trust Corp292,217$970K0.0%-9.3%0.611% 5/12/2021Geode Capital Management LLC443,810$1.47M0.0%+5.7%0.927% 5/7/2021BlackRock Inc.1,529,325$5.08M0.0%+1.7%3.803% Nvidia warning urgent (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you.2/19/2021JPMorgan Chase & Co.69,725$278K0.0%+599.8%0.174% 2/16/2021Charles Schwab Investment Management Inc.162,804$648K0.0%+4.3%0.405% 2/11/2021Northern Trust Corp322,099$1.28M0.0%-0.8%0.802% 2/11/2021Barclays PLC8,601$34K0.0%-29.1%0.021% 2/10/2021Rhumbline Advisers33,364$133K0.0%+20.0%0.083% 2/10/2021Renaissance Technologies LLC39,733$158K0.0%-33.3%0.099% 2/9/2021Wells Fargo & Company MN37,814$151K0.0%+31.2%0.094% 2/9/2021Bank of New York Mellon Corp71,568$285K0.0%-4.5%0.178% 2/5/2021BlackRock Inc.1,503,924$5.99M0.0%+0.6%3.745% 11/10/2020State Street Corp445,336$1.17M0.0%+2.8%1.110% 11/6/2020BlackRock Inc.1,494,861$3.93M0.0%-1.1%3.724% (Data available from 1/1/2016 forward) ELOX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ELOX shares? During the previous two years, the following institutional investors and hedge funds held shares of Eloxx Pharmaceuticals shares: Armistice Capital LLC ($1.32M), American Financial Group Inc. ($67K), and Harel Insurance Investments & Financial Services Ltd. ($54K), Clal Insurance Enterprises Holdings Ltd ($27K).Learn more on ELOX's institutional investors. What percentage of Eloxx Pharmaceuticals stock is owned by institutional investors? 2.90% of Eloxx Pharmaceuticals stock is owned by institutional investors. Learn more on ELOX's institutional investor holdings. Which institutional investors have been buying Eloxx Pharmaceuticals stock? The following institutional investors have purchased Eloxx Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($275K). How much institutional buying is happening at Eloxx Pharmaceuticals? Institutional investors have bought a total of 275,000 shares in the last 24 months. This purchase volume represents approximately $1.32M in transactions. Which Eloxx Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Eloxx Pharmaceuticals stock in the last 24 months: American Financial Group Inc. ($1.44M), Harel Insurance Investments & Financial Services Ltd. ($1.15M), and Clal Insurance Enterprises Holdings Ltd ($570.37K). How much institutional selling is happening at Eloxx Pharmaceuticals? Institutional investors have sold a total of 3,160,365 shares in the last 24 months. This volume of shares sold represents approximately $5.75M in transactions. Related Companies Alvotech Institutional Ownership VectivBio Institutional Ownership Pieris Pharmaceuticals Institutional Ownership Luna Innovations Institutional Ownership Precigen Institutional Ownership Anavex Life Sciences Institutional Ownership PTC Therapeutics Institutional Ownership Amgen Institutional Ownership Gilead Sciences Institutional Ownership argenx Institutional Ownership This page (NASDAQ:ELOX) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eloxx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eloxx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
